Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Skin Neoplasms × dabrafenib × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 4 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Melanoma 3 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma of Lung 1

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04544202 2024-11-12

Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection

Novartis

No longer available

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡